177 related articles for article (PubMed ID: 17885853)
1. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
Kim K; Quesada J; Szmaydy-Rikken N; Darken P; Shah T
J Asthma; 2007 Sep; 44(7):515-20. PubMed ID: 17885853
[TBL] [Abstract][Full Text] [Related]
2. Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis.
Ratner P; Darken P; Wingertzahn M; Shah T
J Asthma; 2007 Oct; 44(8):629-33. PubMed ID: 17943573
[TBL] [Abstract][Full Text] [Related]
3. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
Derom E; Louis R; Tiesler C; Engelstätter R; Kaufman JM; Joos GF
Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
Xu J; Nave R; Lahu G; Derom E; Derendorf H
J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis.
Chervinsky P; Kunjibettu S; Miller DL; Prenner BM; Raphael G; Hall N; Shah T
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):69-76. PubMed ID: 17650833
[TBL] [Abstract][Full Text] [Related]
6. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
[TBL] [Abstract][Full Text] [Related]
7. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
[TBL] [Abstract][Full Text] [Related]
8. Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma.
Magnussen H; Hofman J; Staneta P; Lawo JP; Hellwig M; Engelstätter R
J Asthma; 2007 Sep; 44(7):555-63. PubMed ID: 17885859
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.
Korn S; Buhl R
Respir Med; 2012 Jan; 106(1):57-67. PubMed ID: 21890335
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
11. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia.
Webb DR; Meltzer EO; Finn AF; Rickard KA; Pepsin PJ; Westlund R; Cook CK
Ann Allergy Asthma Immunol; 2002 Apr; 88(4):385-90. PubMed ID: 11995670
[TBL] [Abstract][Full Text] [Related]
12. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
[TBL] [Abstract][Full Text] [Related]
14. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
Vargas R; Dockhorn RJ; Findlay SR; Korenblat PE; Field EA; Kral KM
J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
[TBL] [Abstract][Full Text] [Related]
15. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
Patel D; Ratner P; Clements D; Wu W; Faris M; Philpot E
Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
[TBL] [Abstract][Full Text] [Related]
17. Ciclesonide, a hypotonic intranasal corticosteroid.
Neffen H; Wingertzahn MA
Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
[TBL] [Abstract][Full Text] [Related]
18. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
[TBL] [Abstract][Full Text] [Related]
19. Adherence to asthma controller medication regimens.
Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
